Patient and Provider Perspectives on Symptom Monitoring During Outpatient Chemotherapy: Interview Study
BackgroundFluctuating symptoms and side effects are common during outpatient cancer treatment, and approaches to monitoring symptoms vary widely across providers, patients, and clinical settings. To design a remote symptom monitoring system that patients and providers find to...
Main Authors: | Leeann Chen, Christianna Bartel, Xinlu Cai, Yanghuidi Cheng, Adam Perer, Sean McClaine, Elizabeth Kairis, Krina Durica, Weiyu Huang, Carissa A Low |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2023-04-01
|
Series: | JMIR Formative Research |
Online Access: | https://formative.jmir.org/2023/1/e46001 |
Similar Items
-
Ron Receptor Tyrosine Kinase Activation Confers Resistance to Tamoxifen in Breast Cancer Cell Lines
by: Rebecca J. McClaine, et al.
Published: (2010-08-01) -
Prevalence of symptoms, with a focus on fatigue, and changes of symptoms over three months in outpatients receiving cancer chemotherapy
by: E Spichiger, et al.
Published: (2011-11-01) -
Pain symptoms in depressed outpatients
by: Ahmad Qabil, Khalib
Published: (2009) -
Assessment of elderly fragility in outpatient chemotherapy treatment
by: Josiane Caroline Zimmermann, et al.
Published: (2017-09-01) -
Diagnosing major depression in medical outpatients: acceptability of telephone interviews.
by: Allen, K, et al.
Published: (2003)